SEC Form 4 · accession 0001209191-18-008432
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J. Ambrogi
Officer — Chief Operating Officer
Period of report
Feb 6, 2018
Accepted (ET)
Feb 8, 2018 · 4:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Feb 6, 2018 | M | 50,000 | $0.23 | A | 74,087 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Buy Ordinary SharesF1 | $0.23 | Feb 6, 2018 | M | 50,000 | D | — | Jan 10, 2019 | Ordinary Shares | 50,000 | 74,087 | D |
Explanation of responses
- F1Fully vested and currently exercisable as of the date hereof.